In addition, PPARβ/δ was identified as a key component of the angiogenic switch during tumor progression [25] and VEGF, which is the major mediator of angiogenesis, was identified as a target of PPARβ/δ [18]. This evidence concerns the gene VEGFA and neoplasm.